A carregar...
Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event
This report assesses the observed risk of PML in patients treated with the anti-CD20 monoclonal antibody rituximab in the regulatory authority-approved autoimmune indications rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), and microscopic polyangiitis (MPA). This was a cumulative...
Na minha lista:
| Publicado no: | J Neurovirol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5992248/ https://ncbi.nlm.nih.gov/pubmed/29508305 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13365-018-0615-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|